The Pharmacy Chemistry Branch of the Faculty of Pharmacy held a panel discussion entitled "Designing and Manufacturing New Isotopes" Of nucleosides as possible antiviral hepatitis C) by Dr. Badr Saleh where He showed through his lecture that despite the progress made in the treatment of hepatitis F patients, Type C, but it is still an important cause of liver disease due to its silent nature and is considered research A comprehensive treatment of the disease is a challenge because there are seven genetic types of virus and many species. subsidiary, which in many cases may lead to the use of multiple treatments to cope with the disease. The doctor also explained that the discovery of several points to disrupt the life cycle of the virus and stop the manufacture of proteins Viral has contributed to the discovery of effective antiviral treatments, including the identification of crystalline composition. For viral protein (NS5B) because it is considered the machine for the production of viral DNA. It's done. The choice of this viral protein as a goal for the design and development of antivirals because it is not It exists in humans because the effective location of this protein is preserved in the various genetic species of virus. Hepatitis C. In this research was manufactured 2-C- eoridine acetylcholine and 2-C-(1- Hydroxy) Ethel is eurydin. These compounds are expected to give vital anti-virus anti-virus anti-virus-type (C) and may be developed in the form of drugs in the future.